According to Michael Saylor (@saylor) via Financial Times, MicroStrategy’s cumulative $40 billion Bitcoin investment highlights a significant vote of confidence from institutional participants in the crypto market. This large-scale acquisition, as reported on May 14, 2025, reinforces Bitcoin’s role as a treasury asset and signals potential for further upward price momentum and liquidity influx in the broader cryptocurrency market, especially as other corporate treasuries may follow suit (Source: FT via @saylor, 2025-05-14).

According to Crypto Rover, NASDAQ-listed Bionexus Gene Lab has officially approved Ethereum as its primary treasury asset. This decision marks a significant endorsement for Ethereum, potentially influencing its market position and investor confidence.